Myopia control aims to slow down the progression or worsening of myopia in children and teenagers, so that their final amount of myopia is less than what it would have been without treatment.

Myopia control is important to both improve your child or teenagers' vision with less frequent changes in prescription in childhood, as well as reducing their lifelong risk of eye diseases and vision impairment associated with higher levels of myopia.

Myopia control treatments include special types of spectacle lenses, soft contact lenses, ortho-k and atropine eye drops.

The global Myopia Control Management in Children and Teenagers market size is projected to grow from US$ million in 2024 to US$ million in 2030; it is expected to grow at a CAGR of % from 2024 to 2030.

ReportPrime's newest research report, the “Myopia Control Management in Children and Teenagers Industry Forecast” looks at past sales and reviews total world Myopia Control Management in Children and Teenagers sales in 2022, providing a comprehensive analysis by region and market sector of projected Myopia Control Management in Children and Teenagers sales for 2023 through 2029.

This Insight Report provides a comprehensive analysis of the global Myopia Control Management in Children and Teenagers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity.

This report also analyses the strategies of leading global companies with a focus on Myopia Control Management in Children and Teenagers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Myopia Control Management in Children and Teenagers market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Myopia Control Management in Children and Teenagers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity.

With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Myopia Control Management in Children and Teenagers.

United States market for Myopia Control Management in Children and Teenagers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

China market for Myopia Control Management in Children and Teenagers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Europe market for Myopia Control Management in Children and Teenagers is estimated to increase from US$ million in 2023 to US$ million by 2030, at a CAGR of % from 2024 through 2030.

Global key Myopia Control Management in Children and Teenagers players cover:

• HOYA Corporation
• ZEISS
• EssilorLuxottica
• CooperVision
• Ovctek

In terms of revenue, the global two largest companies occupied a share nearly % in 2023.

This report presents a comprehensive overview, market shares, and growth opportunities of Myopia Control Management in Children and Teenagers market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Spectacles for Myopia Control
• Soft Contact Lenses for Myopia Control
• Ortho-k Contact Lenses
• Atropine Eye Drops

Segmentation by Application:

• Children
• Teenagers

This report also splits the market by region:

• Americas
  • United States
  • Canada
  • Mexico
  • Brazil
• APAC
  • China
  • Japan
  • Korea
  • Southeast Asia
  • India
  • Australia
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
• Middle East & Africa
  • Egypt
  • South Africa
  • Israel
  • Turkey
  • GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration:

• HOYA Corporation
• ZEISS
• EssilorLuxottica
• CooperVision
• Ovctek
• Alpha Corporation
• EUCLID
• Brighten Optix
• Lucid Korea
• WeiXing Optical
• Contex
• Jiangsu Green Stone Optical (SETO)
• Conant
• Aspen
• ENTOD Pharmaceuticals
• Santen Pharmaceutical
• Shenyang Xingqi Pharmaceutical